Nov 2022 | National Clinical Study Group (NKSG) | Charité University Medicine Berlin National Clinical Study Group
Charité launches clinical trial on Long COVID and Chronic Fatigue Syndrome ME/CFS
A National Clinical Study Group (NKSG) is being established at Charité – Universitätsmedizin Berlin to conduct the first clinical trials with drugs for the treatment of Long COVID and Chronic Fatigue Syndrome (ME/CFS). The project is funded by the Federal Ministry of Education and Research (BMBF) with about ten million euros.
© Copyright: Charité
National Clinical Study Group (NKSG)
The National Clinical Study Group (NKSG) is an interdisciplinary network of physicians and scientists with the aim of developing translational research and therapy studies for the treatment of Chronic Fatigue Syndrome (ME/CFS) and Long COVID. The studies will be conducted at the Experimental and Clinical Research Center (ECRC), a joint facility of Charité and the Max Delbrück Center, and at the Department of Neurology with Experimental Neurology at Charité.
Charité University Medicine Berlin National Clinical Study Group
The Charité - Universitätsmedizin Berlin is a world-renowned institution for medical research, education and high-performance medicine and one of the largest hospitals in Europe. It combines, both, university research and teaching in its medical faculty and care of patients in its university hospital. In the process, both, basic research and application-oriented research contiguous to the hospital are further developed through interdisciplinary networking. The Charité is responsible for the university education of the next generation of human and dental doctors and provides further education offers in the field of health sciences.